Jan-08-21 Upgrade
Credit Suisse
Neutral → Outperform
$490 → $556
Dec-16-20 Downgrade
Citigroup
Buy → Neutral
$550 → $500
Dec-02-20 Initiated
Goldman
Buy
$570
Nov-10-20 Initiated
KeyBanc Capital Markets
Sector Weight
$550
Sep-30-20 Initiated
Atlantic Equities
Overweight
$494
Sep-14-20 Initiated
Morgan Stanley
Overweight
$485
Aug-20-20 Resumed
JP Morgan
Overweight
$460
Jul-15-20 Upgrade
Cleveland Research
Neutral → Buy
Jul-07-20 Reiterated
Needham
Buy
$383 → $415
Apr-23-20 Reiterated
Needham
Buy
$341 → $383
Jan-31-20 Reiterated
Needham
Buy
$331 → $341
Jan-22-20 Initiated
Credit Suisse
Neutral
$341
Jan-08-20 Initiated
Wells Fargo
Equal Weight
$350
Jan-07-20 Initiated
Citigroup
Buy
$380
Nov-15-19 Initiated
Stifel
Buy
Jul-25-19 Reiterated
Needham
Buy
$315 → $321
Jul-16-19 Downgrade
Needham
Strong Buy → Buy
$315
May-30-19 Initiated
Wolfe Research
Outperform
May-23-19 Reiterated
Needham
Strong Buy
$313 → $315
Apr-22-19 Reiterated
Needham
Strong Buy
$271 → $312
Jan-16-21 08:00AM Investor's Business Daily
Jan-15-21 05:50PM
06:30AM
Jan-14-21 12:28PM
09:06AM
Jan-13-21 04:26PM
04:40AM
Jan-12-21 10:14AM
Jan-08-21 01:05PM
12:48PM
Jan-06-21 05:45PM
08:00AM
08:00AM
Jan-05-21 04:01PM
12:10PM
06:57AM
Jan-04-21 12:00AM
Dec-31-20 05:45PM
Dec-30-20 04:05PM
Dec-23-20 05:45PM
08:00AM Investor's Business Daily
Dec-22-20 10:00AM
Dec-21-20 11:38AM
09:33AM
08:50AM
08:48AM
Dec-18-20 08:57AM
08:00AM Investor's Business Daily
Dec-17-20 05:45PM
04:24PM
06:09AM
Dec-16-20 02:01PM
11:57AM
09:07AM
08:00AM
Dec-15-20 12:00PM
09:49AM
09:47AM
Dec-14-20 11:46AM
10:00AM
06:08AM
Dec-11-20 05:45PM
08:20AM
Dec-10-20 11:34AM
08:51AM
Dec-09-20 11:39AM
11:38AM
09:30AM
09:27AM
08:18AM
Dec-08-20 12:57PM
12:45PM
10:18AM
10:12AM
10:00AM
06:15AM
06:13AM
Dec-07-20 06:13PM
12:02PM
11:24AM
09:53AM
09:32AM
08:04AM
07:30AM Investor's Business Daily
Dec-04-20 09:37AM
08:58AM
08:45AM
08:41AM
06:52AM
Dec-03-20 12:15PM
08:55AM
08:37AM
Dec-02-20 11:34AM
11:08AM
11:06AM
10:45AM
08:46AM
Dec-01-20 11:10AM Investor's Business Daily
Nov-30-20 01:44PM
11:30AM
11:19AM
10:42AM Investor's Business Daily
10:35AM
09:24AM
08:00AM
Nov-27-20 09:21AM
Nov-26-20 09:18AM
09:06AM
08:58AM
Nov-25-20 03:15PM Investor's Business Daily
03:05PM
01:53PM
08:59AM
08:41AM
07:47AM
07:44AM
Nov-24-20 03:55PM
12:53PM
11:13AM
09:16AM
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrodinger, Inc.; an agreement with Daiichi Sankyo; collaboration with Northeastern University; and partnership with Boys & Girls Clubs of America. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stevenson Mark Executive Vice President & COO Dec 07 Option Exercise 129.77 23,825 3,091,770 67,717 Dec 08 04:31 PM Stevenson Mark Executive Vice President & COO Dec 07 Sale 473.84 14,133 6,696,781 53,584 Dec 08 04:31 PM Stevenson Mark Executive Vice President & COO Dec 04 Option Exercise 129.77 23,825 3,091,770 58,005 Dec 08 04:31 PM Stevenson Mark Executive Vice President & COO Dec 04 Sale 476.46 14,113 6,724,280 43,892 Dec 08 04:31 PM CASPER MARC N Chairman & CEO Nov 02 Sale 484.09 15,000 7,261,350 54,330 Nov 04 04:09 PM CASPER MARC N Chairman & CEO Oct 27 Sale 487.83 10,000 4,878,287 211,594 Oct 28 05:18 PM CASPER MARC N Chairman & CEO Oct 26 Sale 479.94 10,000 4,799,386 221,594 Oct 28 05:18 PM Stevenson Mark Executive Vice President & COO Aug 25 Option Exercise 131.07 22,000 2,883,540 56,561 Aug 27 04:22 PM Stevenson Mark Executive Vice President & COO Aug 25 Sale 420.16 22,000 9,243,520 34,561 Aug 27 04:22 PM Stevenson Mark Executive Vice President & COO Aug 24 Option Exercise 131.07 22,000 2,883,540 70,621 Aug 25 04:04 PM Stevenson Mark Executive Vice President & COO Aug 24 Sale 429.55 22,000 9,450,100 48,621 Aug 25 04:04 PM HORNSTRA PETER E VP & Chief Accounting Officer Aug 18 Option Exercise 136.50 3,337 455,512 19,862 Aug 19 04:20 PM HORNSTRA PETER E VP & Chief Accounting Officer Aug 18 Sale 418.82 3,337 1,397,619 18,212 Aug 19 04:20 PM CASPER MARC N Chairman & CEO Jul 31 Option Exercise 131.07 20,000 2,621,400 260,446 Aug 03 04:32 PM CASPER MARC N Chairman & CEO Jul 31 Sale 409.02 20,000 8,180,400 240,446 Aug 03 04:32 PM CASPER MARC N Chairman & CEO Jul 30 Option Exercise 131.07 20,000 2,621,400 260,446 Aug 03 04:32 PM CASPER MARC N Chairman & CEO Jul 30 Sale 405.31 20,000 8,106,200 240,446 Aug 03 04:32 PM CASPER MARC N Chairman & CEO Jul 29 Option Exercise 131.07 20,000 2,621,400 260,446 Jul 30 07:49 PM Williamson Stephen Sr. VP and CFO Jul 29 Option Exercise 131.07 19,800 2,595,186 57,789 Jul 31 04:03 PM Williamson Stephen Sr. VP and CFO Jul 29 Sale 410.83 19,800 8,134,471 37,989 Jul 31 04:03 PM CASPER MARC N Chairman & CEO Jul 29 Sale 411.05 20,000 8,221,015 240,446 Jul 30 07:49 PM CASPER MARC N Chairman & CEO Jul 28 Option Exercise 131.07 20,000 2,621,400 260,446 Jul 30 07:49 PM CASPER MARC N Chairman & CEO Jul 28 Sale 411.62 20,000 8,232,400 240,446 Jul 30 07:49 PM CASPER MARC N Chairman & CEO Jul 27 Option Exercise 131.07 20,000 2,621,400 260,446 Jul 28 04:13 PM Jafry Syed A. Sr. Vice President Jul 27 Option Exercise 181.08 20,513 3,714,479 27,219 Jul 29 04:09 PM Jafry Syed A. Sr. Vice President Jul 27 Sale 414.94 20,513 8,511,646 21,019 Jul 29 04:09 PM CASPER MARC N Chairman & CEO Jul 27 Sale 404.40 20,000 8,088,000 240,446 Jul 28 04:13 PM Stevenson Mark Executive Vice President & COO Jul 24 Option Exercise 124.28 25,000 3,107,000 73,621 Jul 28 04:06 PM CASPER MARC N Chairman & CEO Jul 24 Option Exercise 131.07 20,000 2,621,400 260,446 Jul 28 04:13 PM CASPER MARC N Chairman & CEO Jul 24 Sale 403.37 20,000 8,067,400 240,446 Jul 28 04:13 PM Stevenson Mark Executive Vice President & COO Jul 24 Sale 404.58 25,000 10,114,465 48,621 Jul 28 04:06 PM MANZI JIM P Director Jul 24 Sale 402.38 3,218 1,294,865 18,986 Jul 28 04:01 PM CASPER MARC N Chairman & CEO Jun 02 Option Exercise 124.28 14,795 1,838,723 289,741 Jun 04 04:37 PM CASPER MARC N Chairman & CEO Jun 02 Sale 349.55 14,795 5,171,606 274,946 Jun 04 04:37 PM CASPER MARC N Chairman & CEO Jun 01 Option Exercise 124.28 20,000 2,485,600 294,946 Jun 02 04:19 PM Williamson Stephen Sr. VP and CFO Jun 01 Sale 348.00 2,500 870,000 37,989 Jun 02 04:21 PM CASPER MARC N Chairman & CEO Jun 01 Sale 349.89 20,000 6,997,718 274,946 Jun 02 04:19 PM CASPER MARC N Chairman & CEO May 29 Option Exercise 124.28 20,000 2,485,600 294,946 Jun 02 04:19 PM CASPER MARC N Chairman & CEO May 29 Sale 349.26 20,000 6,985,200 274,946 Jun 02 04:19 PM Stevenson Mark Executive Vice President & COO May 18 Option Exercise 124.28 25,000 3,107,000 73,621 May 20 04:47 PM CASPER MARC N Chairman & CEO May 18 Option Exercise 124.28 16,705 2,076,097 291,651 May 20 05:07 PM Stevenson Mark Executive Vice President & COO May 18 Sale 348.78 25,000 8,719,575 48,621 May 20 04:47 PM CASPER MARC N Chairman & CEO May 18 Sale 349.44 16,705 5,837,472 274,946 May 20 05:07 PM CASPER MARC N Chairman & CEO Apr 28 Option Exercise 124.28 30,000 3,728,400 304,946 Apr 29 04:22 PM CASPER MARC N Chairman & CEO Apr 28 Sale 333.02 30,000 9,990,609 274,946 Apr 29 04:22 PM Stevenson Mark Executive Vice President & COO Apr 24 Option Exercise 124.28 25,000 3,107,000 73,538 Apr 27 06:55 PM Stevenson Mark Executive Vice President & COO Apr 24 Sale 328.03 25,000 8,200,655 48,538 Apr 27 06:55 PM Williamson Stephen Sr. VP and CFO Mar 04 Option Exercise 124.28 8,700 1,081,236 49,189 Mar 05 04:34 PM Stevenson Mark Executive Vice President & COO Mar 04 Option Exercise 124.28 25,000 3,107,000 73,538 Mar 05 04:59 PM Stevenson Mark Executive Vice President & COO Mar 04 Sale 324.28 25,000 8,107,000 48,538 Mar 05 04:59 PM Williamson Stephen Sr. VP and CFO Mar 04 Sale 318.54 8,700 2,771,298 40,489 Mar 05 04:34 PM Lagarde Michel Executive Vice President Mar 04 Sale 318.54 12,000 3,822,480 26,385 Mar 05 04:28 PM Lagarde Michel Executive Vice President Mar 03 Sale 319.81 12,000 3,837,720 38,385 Mar 05 04:28 PM Williamson Stephen Sr. VP and CFO Mar 02 Sale 291.03 2,500 727,575 40,489 Mar 04 04:00 PM CASPER MARC N Chief Executive Officer Feb 11 Option Exercise 124.28 30,000 3,728,400 278,731 Feb 13 04:07 PM CASPER MARC N Chief Executive Officer Feb 11 Sale 337.13 30,000 10,114,048 248,731 Feb 13 04:07 PM MANZI JIM P Director Feb 05 Sale 332.32 4,410 1,465,531 21,632 Feb 06 04:32 PM Williamson Stephen Sr. VP and CFO Feb 03 Sale 319.13 3,268 1,042,917 34,402 Feb 05 05:59 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite